Delivery Order SPE2DB24D1104-SPE2DB24FYAT3

Award Date 7/23/24
Potential Completion Date 8/13/24
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a ceiling value of $7,106.87 and is a Firm Fixed Price Delivery Order, with a period of performance through June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This federal contract award is for the delivery of the prescription drug ERLEADA 60 MG TABLET UU 120S to the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $7,306.27. The contract is a delivery order with a firm fixed price pricing type and has an ultimate...
This federal contract award is for the delivery of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $7,558.78, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 24, 2025 and is a firm fixed-price delivery order. There is no set-aside designation for this contract. AmerisourceBergen holds a significant...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product, with a ceiling value of $7,558.78. The contract is a firm-fixed price arrangement with a completion date of June 11, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for...
This federal contract award, valued at $7,352.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of March 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $15,117.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product, to support military...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order (DO) valued at $7,558.78 with a firm fixed price. The contract is for the supply of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,704.98 firm-fixed-price delivery order is for the supply of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 3, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product, with a ceiling value of $15,117.58 and a period of performance through July 24, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price delivery order is for 120 units of the medication ERLEADA 60 MG TABLET, with a performance period ending on July 29, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to supply a...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FYAT3
    Delivery Order

This federal contract award is for the delivery of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a ceiling value of $7,306.27 and is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and medical supplies, from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/22/24, 9:19 AM